An Open-Label, Single Arm, Multi-Centered Clinical Trial on the Hemodynamics and Safety of Nesiritide in the Treatment of Patients With Acute Decompensate Heart Failure.
Phase of Trial: Phase III
Latest Information Update: 25 Apr 2014
At a glance
- Drugs Nesiritide (Primary)
- Indications Decompensated heart failure
- Focus Therapeutic Use
- Sponsors Xian-Janssen
- 26 Mar 2010 Actual number of patients added to 40 as reported by ClinicalTrials.gov.
- 29 Dec 2008 New trial record.